Duplicate Document
This document appears to be a copy. The original version is:
From: Jeffrey Epstein <jeevacation@gmail.com>Case File
efta-efta00929752DOJ Data Set 9OtherFrom: Jeffrey Epstein <jeevacation@gmail.com>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00929752
Pages
4
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <jeevacation@gmail.com>
To: "Barrett, Paul S"
Subject: Re: Knock Out and NRG bonds
Date: Tue, 21 Feb 2012 22:05:36 +0000
ok
On Tue, Feb 21, 2012 at 3:20 PM, Barrett, Paul S <
> wrote:
Our Felcor bonds have done really well with the yield now below 5%. We own $2.3MM face. I would like to get our Ally
position up to $SMM (we own $2.9MM face). Therefore I think we should rotate out of the Felcor bonds into the Ally
Pfds. We would buy the Ally A Pfds (ytw 9.30%) which are trust preferreds and higher up on the capital structure than
our Ally B Pfds. I like have a mix of both.
Let me know
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(W)
(F)
NMLS ID# 853441
EFTA00929752
From: jeffrey epstein [mailto:jeeyacationegmail.com]
Sent: Tuesday, February 21, 2012 2:54 PM
To: Barrett, Paul S
Subject: Re: Knock Out and NRG bonds
Yes
Sony for all the typos .Sent from my iPhone
On Feb 21, 2012, at 8:41 AM, "Barrett, Paul S"
Jeffrey
We knocked out on our short BRL put option. We took in $125K 3 weeks ago.
Can I buy 1MM of the NRG bonds?
Thanks
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(W)
(F)
NMLS IDtt 853441
> wrote:
EFTA00929753
From: Barrett, Paul S
Sent: Friday, February 17, 2012 1:53 PM
To: 'Jeffrey epstein'
Cc: Giuffrida, David 3
Subject: To Do - NRG bonds - reiterate OW
Jeffrey
We should buy SImm of this bond. Ytw 7.625%.
Dave Katz reiterates OW in his initiation of a high yield utility monthly.
We reiterate our Overweight on NRG credit and update our NRG financial model in advance of earnings. We estimate that
the company generated $384 million of EBITDA in 4Q11. We expect NRG will address the lower natural gas price environment
and how it will impact, if at all, its timeline to refinance the 2017 notes and the company's shareholder friendly actions (i.e.,
dividends and
share repurchases). We model a pick-up in shareholder friendly activities; this assumption may prove conservative if the company
does not refinance the 2017 notes and given that NRG may flex the activities down to help guard cash.
Despite these assumptions, and using the current natural gas forward price curve (NGA <CMDTY> <GO> CCRV <GO>), we
expect gross recourse debt leverage would increase from 4.2x to 5.3x at the end of 2013, before falling to 4.3x at the end of 2014.
We believe NRG Energy is set up to survive an extended period of low power prices.
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(W)
(F)
NMLS ID# 853441
EFTA00929754
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal
privilege, and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
<Short Circuit.pdf>
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00929755
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jeeyacationegmail.comEmail
jeevacation@gmail.comURL
http://www.jpmorgan.com/pages/disclosures/emailWire Ref
refinanceRelated Documents (6)
DOJ Data Set 10Financial RecordUnknown
EFTA01682184
186p
OtherUnknown
FEDWIRE PAYMENT DEBIT ADVICE
DOJ EFTA Data Set 10 document EFTA01273102
16p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.